Dott.ssa Annalisa Agangi

1. Antonietta Lambiase, Annalisa Agangi, et al In Vitro Resistance to Macrolides and Clindamycin by Group B Streptococcus Isolated from Pregnant and Nonpregnant Women Infectious Diseases in Obstetrics and Gynecology Volume 2012, Article ID 913603,
2. G.M. Maruotti, A. Agangi & P. Martinelli. Chorionic villus sampling and the thalassemia a trait: which relathionship whit pre-eclampsia? BJOG An International Journal of Obstetrics and Gynaecology 2011
3. Napolitano R, et al . Prevalence and characteristics of symptomatic and asymptomatic toboovarian masses in women with HIV:an ultrasonographic study. International J of STD and AIDS 2010,21:472-476.
4. Cannovo N, Agangi A, et al ethic l and legal reflections about the fetal protection by a pregnant woman suffering, in comorbidity, from HIV infection. Matern Fetal Neonatal Med. 2009 Aug 20:1-2_
5. Simioli S, et al Fetal borderline cerebral ventriculomegaly: clinical significance and management. Minerva Ginecol. 2009 Apr;61(2):109-12 _
6. Maruotti GM, Agangi A, et al Prenatal diagnosis of Ulbright-Hodes syndrome J Ultrasound Med. 2009 Mar;28(3):385-8.
7. Martinelli P, Agangi A, et al An important clinical lesson from a patient infected with HIV with diabetic nephropathy and retinopathy. BMJ Case Rep. 2009;
8. Martinelli P, Agangi A, et al Epidemiological and clinical features of pregnant women with HIV: a 21-year perspective from a highly specialized regional center in southern Italy. HIV Clin Trails 2008;9:36-42.
9. Agangi A, et al OC164: The role of targeted fetal ultrasound in women with acute toxoplasmosis in pregnancy. Ultrasound Obstet Gynecol. 2007 Oct;30(4):417.
10. Martinelli P, Agangi A, Maruotti GM. Screening for toxoplasmosis in pregnancy. Lancet 2007;369:823-4.
11. Martinelli P, et al Is uterine artery embolization for cervical ectopic pregnancy always safe? J Minim Invasive Gynecol. 2007 Nov-Dec;14(6):758-63
12. Maruotti G.M., Agangi A, et al Early prenatal diagnosis of concordant posterior urethral valves in male monochorionic twins. Prenatal Diagnosis 2006, 26:67-70.
13. Martinelli P, et al Pregnancy in a woman with a history of Budd-Chiari sindrome trated by porto-systemic shunt, protein C deficiency and bicornute uterus. Thromb Haemost 2006;95:1033-4.
14. Agangi A, et al “Split Notochord Syndrome Variant. Prenatal findings and neonatal management”. Prenat Diagnosis 2005;25(1):23-7.
15. Agangi, et al ECS. “Incresed likelihood of further live births in HIV infected women in recent years”. Br J Obstet Gynecol 2005;112:881-8
16. Martinelli, et al “Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report”. J. Endocrinol. Invest. 2004;27:308-310.
17. Coppola A, et al . Recombinant factor VIIa in a patient with Glanzmann’s thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment. Thromb Haemost 2004;92:1450-2 (Letters to the Editor).
18. Martinelli, et al Interferon treatment for pregnant women affected by Essential Thrombocythaemia: case reports and a review”. Am J Obstet Gynecol 2004;191:2016-2020.
19. Martinelli P, Maruotti GM, Agangi A, et al “Prenatal diagnosis of hemifacial microsomia and ipsilateral cerebellar hypoplasia in a fetus with oculoauriculovertebral spectrum”. Ultrasound Obstet Gynecol. 2004 Aug;24(2):199-201. Review
20. Maruotti GM, Paladini D, Agangi A, et al “Prospective prenatal diagnosis of Fraser syndrome variant in a family with negative history”. Prenat Diagn. 2004 Jan;24(1):69-70.
21. Martinelli, Rosa Russo, Annalisa Agangi, Dario Paladini “Prenatal ultrasound diagnosis of frontonasal dysplasia”. Prenat Diagn 2002; 22:375-379. (IP=1.802) (allegato – rif. 4 – Riviste Internazionali – Atto di Notorietà)
22. Paladini, Tartaglione, Agangi, Foglia, Martinelli, Nappi. “Pena-Shokeir phenotype with variable onset in three consecutive pregnancies”. Ultrasound Obstet Gynecol. 2001 Feb;17(2):163-5.
23. Paladini, Tartaglione, Agangi, Teodoro, Forleo, Borghese, Martinelli “The association between congenital heart disease and Down sindrome in prenatal life”. Ultrasound in Obstetrics and Gynecology 2000; 15: 104-108. (IP=1.0806)
24. Paladini, Lamberti, Agangi, Martinelli “Cleidocranial Dysostosis. Prenatal Ultrasound diagnosis of a late onset form”. Ultrasound in Obstetrics and Gynecology 2000 Jul;16(1):100-1. (IP=1.0806)
25. Paparo L, Nocerino R, Ciaglia E, Di Scala C, De Caro C, Russo R, Trinchese G, Aitoro R, Amoroso A, Bruno C, Di Costanzo M, Passariello A, Messina F, Agangi A, Napolitano M, Voto L, Gatta GD, Pisapia L, Montella F, Mollica MP, Calignano A, Puca A, Berni Canani R.
“Butyrate as bioactive human milk protective component against food allergy”. Allergy. 2020 Oct 11.
26. Donadono V, Saccone G, Maruotti GM, Berghella V, Migliorini S, Esposito G, Sirico A, Tagliaferri S, Ward A, Mazzarelli LL, Sarno L, Agangi A, Quaglia F, Zullo F, Martinelli P. “Incidence of toxoplasmosis in pregnancy in Campania: A population-based study on screening, treatment, and outcome.” Eur J Obstet Gynecol Reprod Biol 2019 Sep;240:316-321
27. European Collaborative Study. Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? AIDS 2003;17:711-720;
28 European Collaborative Study. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004;18:2337-2339
29.European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infectious Diseases 2005;40:458-65
30.. European Collaborative Study. Does highly active Antiretroviral Therapy Increase the risk of congenital Abnormalities in Hiv-infected Women? Acquir Immune Defic Syndr Volume 40, Number 1, september 1 2005 Letter to the Editor 116-118
31. European Collaborative Study. The mother-to-child HIV transmission epidemic in Europe: evolutive in the East and established in the West. AIDS 2006,20:1419-1427
32. European Collaborative Study. HIV-Infected pregnant adolescents and youth: results from a European cohort study. Vulnerable Children and Youth Studies, 2006;1:195-204
33. European Collaborative Study. Time to undetectable viral load after HAART initiation in HIV-infected pregnant women. HIV/AIDS CID 2007:44 (15 June) 1647-1656
34. Landes M, Thorne C, Barlow P, Fiore S, Malyuta R, Martinelli P, Posokhova S, Savasi V, Semenenko I, Stelmah A, Tibaldi C, Newell ML. Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe. Eur J Epidemiol. 2007 Oct 10;
35. European Collaborative Study. Levels and patterns of HIV RNA viral load in untreated pregnant women ELSEVIER 2008 ;
36. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Pregnancy Outcomes in Women with Advanced HIV Infection in Italy. AIDS PATIENT CARE and STDs Volume 25, Number 11, 2011 639-645
37. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Glucose Plasma Levels and Pregnancy Outcomes in Women with HIV. HIV Clin Trials 2011;12(6) 299-312
38. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Most of pregnant women with HIV are not on guidelines-preferred drugs at conception, 2012 1-7
39. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational study. J. Antimicrob Chemother 2014;
40. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnanct women with HIV in Italy. HIV Clin Trials 2014;
41. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Is “option B+” also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy. Clin Infect Dis 2015;
42.. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Brief Report:consequences of presentation with advanced Hiv disease in pregnancy:data from a National Study in Italy. J acquir Immune Defic Syndr. 2015;
43. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy, Good prenatal detection rate of major bith defects in HIV-infected pregnant women in Italy. Prenat Diagn 2015 Dec;35(13):1374-8;
44. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy, Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV. Clin Microbiol Infect. 2016 Sep;22(9):818-820;
45. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Rate, correlates and outcomes of repeat pregnancy in HIV-infected women. HIV Med 2017 Jul; 18(69.440-443.
46.. Floridia M, et al. Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy, Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series. BJOG 2017 Jul;124(8):1218-1223.